The Ex Vivo Skin Model as an Alternative Tool for the Efficacy and Safety Evaluation of Topical Products
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
The development of alternative approaches for safety and efficacy testing that avoid the use of animals is a worldwide trend, which relies on the improvement of current models and tools so that they better reproduce human biology. Human skin from elective plastic surgery is a promising experimental model to test the effects of topically applied products. As the structure of native skin is maintained, including cell population (keratinocytes, melanocytes, Langerhans cells and fibroblasts) and dermal matrix (containing collagen, elastin, glycosaminoglycans, etc.), it most closely matches the effects of substances on in vivo human skin. In this review, we present a collection of results that our group has generated over the last years, involving the use of human skin and scalp explants, demonstrating the feasibility of this model. The development of a test system with ex vivo skin explants, of standard size and thickness, and cultured at the air–liquid interface, can provide an important tool for understanding the mechanisms involved in several cutaneous disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6
Kim, B. E., Leung, D. Y. M., Boguniewicz, M., & Howell, M. D. (2008) · Clinical Immunology · doi:10.1016/j.clim.2007.11.006 · Cited by 538
Akdis, C. A., Akdis, M., Bieber, T., Bindslev-Jensen, C., Boguniewicz, M., Eigenmann, P., Hamid, Q., Kapp, A., Leung, D. Y. M., Lipozencic, J., et al. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.03.045 · Cited by 460
Hair follicle aging is driven by transepidermal elimination of stem cells via COL17A1 proteolysis
Matsumura, H., Mohri, Y., Binh, N. T., Morinaga, H., Fukuda, M., Ito, M., Kurata, S., Hoeijmakers, J., & Nishimura, E. K. (2016) · Science · doi:10.1126/science.aad4395 · Cited by 416 · cited 2×
“Studies have demonstrated that the overexpression of COL17A1 delays the miniaturisation of the HF and the depletion of HFSCs, confirming the key role that this protein plays in the process of follicular ageing.(57) This information allowed us to develop an experimental model that can mimic the response to damage cause…”
BackgroundThe tortoise and the hair: slow-cycling cells in the stem cell race
Fuchs, E. (2009) · Cell · doi:10.1016/j.cell.2009.05.002 · Cited by 371
Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis
Jensen, J.-M., Fölster-Holst, R., Baranowsky, A., Schunck, M., Winoto-Morbach, S., Neumann, C., Schütze, S., & Proksch, E. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.22621.x · Cited by 309
Management of Atopic Dermatitis in the Pediatric Population
Krakowski, A. C., Eichenfield, L. F., & Dohil, M. A. (2008) · Pediatrics · doi:10.1542/peds.2007-2232 · Cited by 205
Quality of life of children with atopic dermatitis and their families
McKenna, S. P., & Doward, L. C. (2008) · Current Opinion in Allergy & Clinical Immunology · doi:10.1097/aci.0b013e3282ffd6cc · Cited by 74 · cited 1×
“AD is a highly pruritic chronic inflammatory skin disorder that most commonly affects children, resulting in significant morbidity and an adverse effect on the quality of life.(35,36) AD treatment requires the frequent application of emollients to soften and moisturise the skin, in addition to various types of topical…”
Background
Cited by
Zhang, X., Chen, S., Luo, D., Chen, D., Zhou, H., Zhang, S., Chen, X., Lu, W., & Liu, W. (2023) · Molecules · doi:10.3390/molecules28062738 · Cited by 60
“Due to the complex structure and high internal coordination of the skin, a single-cell model cannot fully reflect the drug interaction with the skin [26,27].”
BackgroundPortugal-Cohen, M., Cohen, D., Kohen, R., & Oron, M. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1215266 · Cited by 24
“Examples of ex vivo human skin models are skin explants, made by taking a small piece of skin tissue from a donor and maintaining it in culture (Eberlin et al., 2020), and skin organoid cultures, made by growing skin tissue in culture under conditions that mimic the in vivo environment, like basal cell carcinoma (BCC)…”
BackgroundIn Vitro and Ex Vivo Models for Screening Topical Anti-Inflammatory Drugs
Pérez-Salas, J. L., Moreno-Jiménez, M. R., Rocha-Guzmán, N. E., González-Laredo, R. F., Medina-Torres, L., & Gallegos-Infante, J. A. (2023) · Scientia Pharmaceutica · doi:10.3390/scipharm91020020 · Cited by 22
“It is important to preserve the structure of the native skin and dermal matrix so that the effects of the applied molecules are similar to the in vivo responses of human skin [87].”
BackgroundRecreating Human Skin In Vitro: Should the Microbiota Be Taken into Account?
Galvan, A., Pellicciari, C., & Calderan, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021165 · Cited by 11
Cousin, I., Misery, L., de Vries, P., & Lebonvallet, N. (2023) · Dermatology · doi:10.1159/000533261 · Cited by 3
Metadata
- Authors
- Eberlin, S., Silva, M. S. D., Facchini, G., Silva, G. H. D., Pinheiro, A. L. T. A., Eberlin, S., & Pinheiro, A. D. S.
- Venue
- Alternatives to Laboratory Animals
- Publisher
- SAGE Publications
- Published
- 2020-01
- Volume
- 48
- Issue
- 1
- Pages
- 10-22
- ISSN
- 0261-1929 (ISSN-L)
- 2632-3559
- OpenAlex
- W3032013791
- Cited by
- 69
- References
- 7
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Ex Vivo Skin Model as an Alternative Tool for the Efficacy and Safety Evaluation of Topical Products. https://app.cochat.ai/papers/10.1177/0261192920914193
- The paper
- Eberlin, S., Silva, M. S. D., Facchini, G., Silva, G. H. D., Pinheiro, A. L. T. A., Eberlin, S., & Pinheiro, A. D. S. (2020). The Ex Vivo Skin Model as an Alternative Tool for the Efficacy and Safety Evaluation of Topical Products. Alternatives to Laboratory Animals. https://doi.org/10.1177/0261192920914193
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.